Earli, Inc.
2 articles about Earli, Inc.
-
Biopharma companies raking in the cash with investment rounds and IPO announcements.
-
Earli Raises $40 Million Series A Funding Led by Khosla Ventures, With Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital
1/12/2021
Platform Designed to Exactly Locate Early Cancer and Thereby Make It Actionable, Based on Novel “Synthetic Biopsy” Technology Licensed from Stanford University